Evidence map›Paper›PMID 27938439›Full record

ArticleParasitology2017

The antileishmanial activity of xanthohumol is mediated by mitochondrial inhibition.

Lianet Monzote, Alexandra Lackova, Katrin Staniek, Silvia Steinbauer, Gerald Pichler, Walter Jäger, Lars Gille

Open access · greenAbstract read
In one paragraph

Article in Parasitology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Phenolic Compounds fromMolecules (Basel, Switzerland) · 2019
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Lianet MonzoteDepartment of Biomedical Sciences,Institute of Pharmacology and Toxicology,University of Veterinary Medicine,A-1210 Vienna,Veterinärplatz 1,Austria.
Alexandra LackovaDepartment of Biomedical Sciences,Institute of Pharmacology and Toxicology,University of Veterinary Medicine,A-1210 Vienna,Veterinärplatz 1,Austria.
Katrin StaniekDepartment of Biomedical Sciences,Institute of Pharmacology and Toxicology,University of Veterinary Medicine,A-1210 Vienna,Veterinärplatz 1,Austria.
Silvia SteinbauerDepartment of Biomedical Sciences,Institute of Pharmacology and Toxicology,University of Veterinary Medicine,A-1210 Vienna,Veterinärplatz 1,Austria.
Gerald PichlerDepartment of Biomedical Sciences,Institute of Pharmacology and Toxicology,University of Veterinary Medicine,A-1210 Vienna,Veterinärplatz 1,Austria.
Walter JägerDepartment of Pharmaceutical Chemistry, Division of Clinical Pharmacy and Diagnostics,University of Vienna,A-1090 Vienna, Althanstraße 14,Austria.
Lars GilleDepartment of Biomedical Sciences,Institute of Pharmacology and Toxicology,University of Veterinary Medicine,A-1210 Vienna,Veterinärplatz 1,Austria.ORCID 0000-0003-1223-0201
University of Veterinary Medicine Vienna · ATUniversity of Vienna · AT

Funding

Austrian Science Fund FWF P 27814
6 · The paper itself

Abstract

Xanthohumol (Xan) is a natural constituent of human nutrition. Little is known about its actions on leishmanial parasites and their mitochondria as putative target. Therefore, we determined the antileishmanial activity of Xan and resveratrol (Res, as alternative compound with antileishmanial activity) with respect to mitochondria in Leishmania amazonensis promastigotes/amastigotes (LaP/LaA) in comparison with their activity in peritoneal macrophages from mouse (PMM) and macrophage cell line J774A.1 (J774). Mechanistic studies were conducted in Leishmania tarentolae promastigotes (LtP) and mitochondrial fractions isolated from LtP. Xan and Res demonstrated antileishmanial activity in LaA [half inhibitory concentration (IC50): Xan 7 µ m, Res 14 µ m]; while they had less influence on the viability of PMM (IC50: Xan 70 µ m, Res >438 µ m). In contrast to Res, Xan strongly inhibited oxygen consumption in Leishmania (LtP) but not in J774 cells. This was based on the inhibition of the mitochondrial electron transfer complex II/III by Xan, which was less pronounced with Res. Neither Xan nor Res increased mitochondrial superoxide release in LtP, while both decreased the mitochondrial membrane potential in LtP. Bioenergetic studies showed that LtP mitochondria have no spare respiratory capacity in contrast to mitochondria in J774 cells and can therefore much less adapt to stress by mitochondrial inhibitors, such as Xan. These data show that Xan may have antileishmanial activity, which is mediated by mitochondrial inhibition.

Indexed as

AnimalsAntiprotozoal AgentsCattleCell LineElectron TransportElectron Transport Complex IIIFemaleFlavonoidsInhibitory Concentration 50LeishmaniaMacrophages, PeritonealMembrane Potential, MitochondrialMiceMice, Inbred BALB CMitochondriaOxidative PhosphorylationAntiprotozoal AgentsElectron Transport Complex IIIFlavonoidsPropiophenonesResveratrolStilbenesSuperoxidesxanthohumolESR spectroscopyLeishmaniamitochondriaresveratrolxanthohumol

Identifiers

PMID27938439
PMCPMC7116497
OpenAlexW2560491920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.